Redox-dependent migration and proliferation of vascular smooth muscle cells (SMCs) are central events in the development of vascular proliferative diseases; however, the underlying intracellular signaling mechanisms are not fully understood. We tested the hypothesis that activation of Nox1 NADPH oxidase modulates intracellular calcium ([Ca 2ϩ ] i ) levels. Using cultured SMCs from wild-type and Nox1 null mice, we confirmed that thrombin-dependent generation of reactive oxygen species requires Nox1. Thrombin rapidly increased [Ca 2ϩ ] i , as measured by fura-2 fluorescence ratio imaging, in wild-type but not Nox1 null SMCs. The increase in [Ca 2ϩ ] i in wild-type SMCs was inhibited by antisense to Nox1 and restored by expression of Nox1 in Nox1 null SMCs. Investigation into potential mechanisms by which Nox1 modulates [Ca 2ϩ ] i showed that thrombin-induced inositol triphosphate generation and thapsigargin-induced intracellular calcium mobilization were similar in wild-type and Nox1 null SMCs. To examine the effects of Nox1 on Ca 2ϩ entry, cells were either bathed in Ca 2ϩ -free medium or exposed to dihydropyridines to block L-type Ca 2ϩ channel activity. Treatment with nifedipine or removal of extracellular Ca 2ϩ reduced the thrombin-mediated increase of [Ca 2ϩ ] i in wild-type SMCs, whereas the response in Nox1 null SMCs was unchanged. Sodium vanadate, an inhibitor of protein tyrosine phosphatases, restored the thrombin-induced increase of [Ca 2ϩ ] i in Nox1 null SMCs. Migration of SMCs was impaired with deficiency of Nox1 and restored with expression of Nox1 or the addition of sodium vanadate. In summary, we conclude that Nox1 NADPH oxidase modulates Ca 2ϩ mobilization in SMCs, in part through regulation of Ca 2ϩ influx, to thereby promote cell migration. (Hypertension. 2011;58:446-453.) • Online Data Supplement
N ADPH oxidases contribute to vascular proliferative diseases. 1, 2 Nox1 is the inducible catalytic subunit of NADPH oxidase in smooth muscle cells (SMCs) and is responsible for cell activation. Nox1 mediates redoxdependent signaling via regulation of gene transcription, resulting in SMC migration and proliferation. 3, 4 The mechanisms by which Nox1-derived reactive oxygen species (ROS) activate cellular signaling are complex and not completely defined. Recent studies have provided evidence linking ROS and Ca 2ϩ signaling in the vasculature. [5] [6] [7] [8] [9] For example, in isolated arterioles, either global inhibition of NADPH oxidase or treatment with ROS scavengers prevents angiotensin II (Ang II)-dependent increases in intracellular calcium ([Ca 2ϩ ] i ). 10 ROS control of Ca 2ϩ signaling can occur through multiple mechanisms, including activation of Ca 2ϩ release from intracellular stores, extracellular Ca 2ϩ entry, or inhibition of Ca 2ϩ reuptake. 6, 8 In vascular cells, ROS increases sensitivity of inositol triphosphate (IP 3 ) receptor to IP 3 and promotes Ca 2ϩ entry via activation of voltage-gated Ca 2ϩ channels. 11, 12 In this study, we used a combination of pharmacological inhibitors and genetic manipulation of Nox1 expression to examine the role of Nox1 activation in modulating [Ca 2ϩ ] i . Our data demonstrate that activation of Nox1 increases [Ca 2ϩ ] i , in part via influx of extracellular Ca 2ϩ involving activation of L-type Ca 2ϩ channel. In addition, the effect of Nox1 on Ca 2ϩ mobilization is required for SMC migration. Redox control of Ca 2ϩ handling is a novel mechanism by which Nox1 can modulate SMC signaling and function.
Materials and Methods

Vascular Smooth Muscle Cell Culture
Thoracic aortas from male Nox1 null (Nox1 Ϫ/y ) 13 and control littermate wild-type (WT; Nox1 ϩ/y ) mice were obtained, and SMCs were isolated and cultured as described previously. 14 The cells were maintained in DMEM supplemented with 10% FBS, 2 mmol/L L-glutamine, 100 U/mL of penicillin, and 100 g/mL of streptomycin at 37°C in a 5% CO 2 humidified incubator. Experiments were performed using cells between passages 4 and 10, and serumdeprived conditions were obtained by incubating 24 hours in DMEM containing 0.1% FBS. Studies conform to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health and were approved by the University of Iowa Institutional Animal Care and Use Committee.
Adenovirus-Mediated Gene Transfer
Experiments used the E1-deleted replication-deficient recombinant adenoviral vectors encoding Nox1 (AdNox1), 15 antisense Nox1 (AdNox1-AS), 16 green fluorescent protein (AdGFP), or empty vector (AdEmpty). Adenovirus was mixed with the cationic polymer poly-L-lysine (250 molecules per virus particle) 17 and added to SMCs in serum-free DMEM. 18 After 4 hours, medium was replaced with DMEM containing 10% FBS for 48 hours.
Detection of ROS
Thrombin-induced changes in ROS levels in Nox1 null and WT SMCs were detected by Amplex Red. SMCs were incubated with Amplex Red (20 mol/L) and horseradish peroxidase (0.2 U/mL) for 30 minutes, after which the fluorescence intensity of the medium was determined (excitation and emission wavelengths of 545 and 590 nm, respectively) and normalized to cell number.
Intracellular Calcium Measurement
Thrombin-stimulated changes in [Ca 2ϩ ] i were assessed by Fura-2 fluorescence ratio imaging using a microscopic digital imaging system (Photon Technology International), as described previously. 19, 20 Briefly, WT or Nox1 null SMCs grown on 25-mm coverslips were loaded with the Ca 2ϩ -specific dye Fura-2acetoxymethyl ester (1 mol/L, Molecular Probes/Invitrogen) for 30 minutes at 37°C. After washing with Hank's balanced salt solution, cells were incubated for 20 minutes at 37°C in Hank's balanced salt solution to allow complete hydrolysis of Fura-2-acetoxymethyl ester to Fura-2. Real-time shifts in Fura-2 ratio fluorescence, indicating changes in [Ca 2ϩ ] i , were recorded before, during, and after stimulating SMCs with thrombin (1 U/mL) or H 2 O 2 (100 mol/L). To examine the role of NADPH oxidase, WT SMCs were pretreated with the NADPH oxidase inhibitor diphenylene iodonium (10 mol/L, Sigma-Aldrich) for 1 hour before thrombin stimulation. In other studies, [Ca 2ϩ ] i was examined in WT SMCs expressing antisense against Nox1 (AdNox1-AS) or Nox1 null SMCs expressing Nox1 (AdNox1). The patency of [Ca 2ϩ ] i stores in SMCs was determined by treating cells with thapsigargin (5 g/mL, Sigma-Aldrich). The contribution of extracellular Ca 2ϩ influx on thrombinmediated increases in [Ca 2ϩ ] i was examined by bathing SMCs in Ca 2ϩ -free Hank's balanced salt solution or treating with nifedipine (1 mol/L) during thrombin stimulation. Summary data represent the average difference in the basal and peak increase in [Ca 2ϩ ] i , except for the dihydropyridine experiments, in which the change in [Ca 2ϩ ] i was determined at all of the time points, and the lowest value was subtracted from the highest value.
IP 3 Levels
Cells were grown in 6-well plates to 80% to 90% confluence, washed with the assay media (inositol-free DMEM containing 20 mmol/L of HEPES, 2 mmol/L of glutamine, 10 g/mL of streptomycin, 10 U/mL of penicillin, and 0.1% BSA) and then incubated in the assay medium containing 4 Ci/mL of [2-3 H]myo-inositol (NEN Life Science Products) for 18 to 24 hours at 37°C. At the end of the labeling period, the cells were incubated with assay medium containing 20 mmol/L of LiCl for 15 minutes at 37°C, followed by the addition of thrombin (1 U/mL) for 5 minutes. Cells were placed on ice, and the medium was quickly aspirated and replaced with equal volumes of cold 1.5 N perchloric acid and 0.5 mol/L of HCIO 4 . After a 30-minute incubation on ice, the extracts were collected, centrifuged, and the supernatants were neutralized by the addition of 0.72 mol/L of KOH/0.6 mol/L of KHCO 3 . The precipitated KClO 4 salt was removed by centrifugation, and the supernatants were mixed with 100 mmol/L of inositol and water. These samples were then used for the assay of inositol phosphates. An ion-exchange resin AG-1-X8 (200 to 400 mesh, formate, Bio-Rad) was rehydrated with water, poured onto 0.5ϫ3.0-cm chromatography columns, and washed once with water and twice with 10 mmol/L of myo-inositol.
The cell extracts were then applied to the columns, followed by several washing steps, including 10 mmol/L of myo-inositol and 5 mmol/L of sodium borate/60 mmol/L of sodium formate solution. The last elution step was performed with 0.1 mol/L of formic acid/1.0 mol/L of ammonium formate solution. This fraction contains inositol phosphates. Samples were counted in a liquid scintillation counter.
Cell Migration
The migration of SMCs was determined by scratch wound assay and by modified Boyden chamber method. Where indicated, cells were infected with AdNox1-AS, AdNox1, or AdGFP for 24 hours, followed by serum starvation for an additional 24 hours. For scratch wound assays, the serum-starved SMC monolayer was disrupted with a sterile cell scraper to create a cell-free zone. Cells were then washed with medium and treated with or without thrombin (1 U/mL) in DMEM containing 0.1% FBS, and images were taken 24 hours after injury using a microscope equipped with a digital camera. For the modified Boyden chamber method, SMC migration was determined in Transwell cell-culture chambers with collagen polycarbonate membrane with 8-m pores. SMCs were grown to Ϸ80% confluence and then made quiescent in 0.1% serum for 48 hours before migration. SMCs (10 6 cells per milliliter) were added to the upper chamber of the transwell and allowed to attach to the membrane for 30 minutes. Chambers contained medium with 0.1% serum. Migration of SMCs was induced by the addition of thrombin (1 U/mL) in the presence or absence of nifedipine (1 mol/L, Sigma Aldrich) or sodium vanadate (200 mol/L, Sigma-Aldrich) to the lower compartment. After 6 hours, nonmigrated cells were removed from the upper chamber. SMCs migrating to the lower surface of the membrane were fluorescently stained with 4Ј,6-diamidino-2phenylindole and quantitated microscopically.
Cell Proliferation
Cell proliferation was determined by measuring [ 3H ]thymidine incorporation into SMCs infected with either AdNox1-AS or AdGFP, as described previously. 21
Statistics
Data are expressed as meanϮSEM and analyzed by the Student t test when comparing only 2 groups and by ANOVA followed by Newman-Keuls correction for multiple comparisons when comparing Ͼ2 groups. A value of PϽ0.05 was defined statistical significance.
Results
Thrombin-Stimulated Increase in [Ca 2؉ ] i Is Dependent on Nox1
Although NADPH oxidase-derived ROS have been implicated in thrombin-mediated SMC proliferation and migration, [22] [23] [24] little is known regarding the second messengers involved in ROS signaling. Therefore, we examined the role of NADPH oxidases in modulating [Ca 2ϩ ] i in response to thrombin. In WT SMCs, thrombin caused a rapid increase in [Ca 2ϩ ] i that was markedly attenuated when cells were pretreated with diphenylene iodonium ( Figure 1A and 1B) , an inhibitor of thrombin-induced ROS ( Figure S1 , available in the online Data Supplement at http://hyper.ahajournals.org). Nox1 is the inducible isoform of NADPH oxidase in SMCs, 25 and we have shown previously that thrombin activates Nox1 ( Figure S1 ). 15 Therefore, we next examined whether Nox1 is responsible for the thrombin-induced increases in [Ca 2ϩ ] i . Thrombin caused a rapid and transient increase in [Ca 2ϩ ] i , peaking 25 to 30 seconds after stimulation ( Figure 2B ). Expression of an antisense targeting Nox1 inhibited thrombin-mediated increase in both ROS levels and in [Ca 2ϩ ] i in WT SMCs (Figure 2) . Similarly, the peak increase in [Ca 2ϩ ] i in Nox1 null SMCs was markedly reduced as compared with WT cells. Heterologous expression of Nox1 in Nox1 null SMCs restored the thrombin-mediated increase in ROS and in [Ca 2ϩ ] i ( Figure 2 ). The effects that we observe are specific to the absence of Nox1-derived ROS, because the addition of H 2 O 2 to WT and Nox1 null SMCs resulted in a similar increase in [Ca 2ϩ ] i (WT: 32Ϯ12%; Nox1 null: 40Ϯ13%; nϭ6). Taken together, these data indicate that Nox1 initiates [Ca 2ϩ ] i mobilization in response to thrombin in SMCs.
Nox1 Mediates Influx of Extracellular Ca 2؉ in Thrombin-Stimulated SMCs
It has been shown previously that the thrombin-mediated increase in [Ca 2ϩ ] i is secondary to the activation of phospholipase C, with a subsequent increase in IP 3 . 26 We assessed whether the observed differences in [Ca 2ϩ ] i between WT and Nox1 null SMCs in response to thrombin resulted from differences in IP 3 generation. WT and Nox1 null SMCs demonstrated a similar increase of IP 3 levels at 5 and 60 minutes after thrombin ( Figure 3A ), indicating that IP 3 levels are independent of Nox1-derived ROS. Furthermore, in response to thapsigargin, an inhibitor of the sarco-endoplasmic reticulum Ca 2ϩ -ATPases, 27 [Ca 2ϩ ] i increased to similar levels in WT and Nox1 null cells ( Figure 3B ), suggesting no difference in IP 3 -sensitive Ca 2ϩ pools.
Based on these observations, we next tested whether Nox1 mediates the influx of extracellular Ca 2ϩ in response to thrombin. When WT cells were bathed in Ca 2ϩ -free medium, the magnitude of increase in [Ca 2ϩ ] i after thrombin was significantly inhibited ( Figure 4A ), confirming influx of extracellular Ca 2ϩ after stimulation with thrombin. In contrast to WT cells, the absence of extracellular Ca 2ϩ had no effect on the thrombin-mediated increase in [Ca 2ϩ ] i in Nox1 null cells ( Figure 4B) . These data suggest that Nox1-derived ROS modulate the influx of extracellular Ca 2ϩ in response to thrombin. To extend these findings, we examined the contribution of L-type Ca 2ϩ channels, because activity of voltagegated Ca 2ϩ channels is known to be regulated by redox modification of cysteine and methionine residues. 7 Treatment with the dihydropyridine nifedipine prevented the thrombinstimulated increase in [Ca 2ϩ ] i ( Figure 5 ). Similar results were obtained with nitrendipine ( Figure S2 ). These findings implicate L-type Ca 2ϩ channel activity as the source of extracellular Ca 2ϩ influx in response to thrombin and a potential target of Nox1-derived ROS.
Inhibition of protein tyrosine phosphatase (PTP) 1B by ROS has been implicated in modulating activity of Ca 2ϩ entry channels, 28 and cellular ROS are known to inactivate PTPs by the reversible oxidation of cysteine residues in the active site, 29 thereby modifying the magnitude and duration of signaling events. Furthermore, it has been shown that PTP inactivation in response to Ang II requires Nox1-derived ROS. 30 Treatment of Nox1 null SMCs with sodium vanadate, an inhibitor of PTPs, partially restored the thrombin-mediated increase in [Ca 2ϩ ] i (vehicle: 0.51Ϯ0.02 mol/L; thrombin: 0.77Ϯ0.03 mol/L; sodium vanadate: 0.58Ϯ0.04 mol/L; sodium vanadate ϩ thrombin: 1.02Ϯ0.07 mol/L; nϭ26 cells; PϽ0.05), identifying inactivation of PTPs as an additional potential mechanism by which Nox1 can influence Ca 2ϩ signaling.
Thrombin-Induced SMC Migration and Proliferation Are Mediated by Nox1
Previous investigators have shown that thrombin mediates proliferation and migration of SMCs. [31] [32] [33] It has also been shown that NADPH oxidase-derived ROS control thrombininduced SMC migration. 22, 23 We examined how the Nox1 regulation of Ca 2ϩ influx affects thrombin-induced migration of SMCs. As compared with control, thrombin increased the distance that WT SMCs migrated; however, thrombininduced migration was abolished in Nox1 null SMCs and reduced in WT SMCs treated with antisense to Nox1 ( Figure  6A ). This approach to measure migration cannot differentiate between the changes in cell growth versus migration. Therefore, we next used the modified Boyden chamber method to further assess the role of Nox1 in migration ( Figure 6B ). Thrombin increased the transmigration of WT SMCs. In contrast, Nox1 null SMCs did not display a similar increase in migration to thrombin. The importance of Nox1 in this response was further verified by the loss of transmigration in WT cells pretreated with Nox1 antisense and the rescue of migration in Nox1 null cells after exogenous expression of Nox1. With regard to proliferation, thrombin-induced DNA synthesis was increased 3-fold in WT SMCs as compared with untreated WT cells but was reduced in SMCs deficient in Nox1 and in WT SMCs expressing Nox1 antisense ( Figure  6C ). These findings are similar to recent reports identifying a role for Nox1 in activation of SMCs by platelet-derived growth factor 3 and basic fibroblast growth factor. 4 We next investigated the role of Ca 2ϩ in Nox1-dependent SMC migration. Consistent with the effects on Ca 2ϩ influx, treatment of WT SMCs with nifedipine prevented transmigration to thrombin ( Figure 6D 
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Nox1 null Nox1 null + Nox1 the thrombin-mediated increase in [Ca 2ϩ ] i in Nox1 null SMCs, we tested the hypothesis that inhibition of PTPs would restore migration of Nox1 null SMCs. There was a trend for sodium vanadate to increase migration of Nox1 null SMCs in the absence of thrombin ( Figure 6E ). The addition of thrombin did not further increase migration of Nox1 null SMCs pretreated with sodium vanadate. These data suggest that PTPs may be downstream effectors of Nox1-mediated redox signaling.
Discussion
Previous studies have identified NADPH oxidase-derived ROS as critical signaling intermediates in SMC migration and proliferation. 3, 4, 22 Herein we show that activation of the Nox1-based NAPDH oxidase by thrombin modulates [Ca 2ϩ ] i levels in SMCs in part via influx of extracellular Ca 2ϩ . In addition, we show that SMC migration involves Nox1dependent increases in [Ca 2ϩ ] i . These effects involve activation of L-type Ca 2ϩ channels and inactivation of PTPs. These are the first data to identify redox control of Ca 2ϩ influx as a mechanism by which Nox1 alters SMC function.
Several lines of evidence suggest that Nox1-derived ROS are critical to the development of vascular disease. We have shown recently that, in a model of hypercholesterolemia, deficiency of Nox1 reduces atherosclerotic lesion area in the aorta. 34 Within days of arterial balloon injury, Nox1 expression and ROS levels are increased in neointimal SMCs, 35 and, after vascular injury, neointimal formation 3 and proliferation 34 are reduced in Nox1 null mice. Genetic manipulation of Nox1 confirms the role of Nox1-derived ROS in cell proliferation 36, 37 and SMC migration. 3, 4 Although these studies provide strong evidence for Nox1 in the pathogenesis of vascular disease, the mechanisms by which Nox1-derived ROS activate SMC is not completely understood. Our data contribute to the field by defining a mechanism by which Nox1 modulates [Ca 2ϩ ] i levels to induce cellular processes.
The activation of SMCs by thrombin involves activation of Nox1 15 and Ca 2ϩ -sensitive signaling pathways 26, 38, 39 ; however, the relationship between ROS and Ca 2ϩ signaling in this context remains unclear. The multiple mechanisms by which ROS regulate intracellular calcium homeostasis, such as activation of Ca 2ϩ release and entry channels and inhibition of Ca 2ϩ reuptake, have been extensively reviewed. Voltagegated Ca 2ϩ channels contain many cysteine and methionine residues susceptible to redox modification that could influence channel function. 7 In addition to direct effects of ROS on calcium channels, oxidation of regulatory proteins, such as calmodulin, may also affect channel function. Changes in the cellular redox state can increase [Ca 2ϩ ] i by inducing Ca 2ϩ influx through voltage-dependent Ca 2ϩ channels, by stimulating IP 3 -mediated Ca 2ϩ mobilization from intracellular stores, by stimulating ryanodine receptors, and by inhibiting activity of sarco-endoplasmic reticulum calcium ATPase or plasma membrane Ca 2ϩ ATPase. [5] [6] [7] [8] Multiple integrated mechanisms regulate [Ca 2ϩ ] i levels. Our data demonstrate that thrombin elicited an acute transient increase in [Ca 2ϩ ] I , followed by sustained phase of elevated [Ca 2ϩ ] i . However, in Ca 2ϩ -free medium, the peak increase in [Ca 2ϩ ] i was significantly inhibited, and the sustained plateau phase was virtually absent, suggesting that thrombin induces an influx of extracellular Ca 2ϩ . The transient changes in [Ca 2ϩ ] i in Nox-1 null SMCs in the presence of Ca 2ϩ mimicked that of WT SMCs in either Ca 2ϩ -free medium or after treatment with nifedipine. These data suggest that Nox1-derived ROS contribute to the thrombin-mediated increase in [Ca 2ϩ ] i through influx of extracellular Ca 2ϩ . ROS have been shown to increase the sensitivity of the IP 3 receptor to promote IP 3 -mediated Ca 2ϩ release. 11 Our observation of no difference in total IP 3 levels in WT versus Nox1 null SMCs does not preclude the possibility that Nox1 activation alters the sensitivity of IP 3 receptor to IP 3 . It has also been demonstrated that ROS sustains Ca 2ϩ influx via inhibition of PTPs, presumably by maintaining phosphorylation of Ca 2ϩ entry channels. 28 In our study, pharmacological inhibition of PTPs in Nox1 null SMCs partially restored thrombin-induced increases in [Ca 2ϩ ] i . These findings are consistent with another study using a rat model of hypertension that found that Nox1-derived ROS is required for Ang II-dependent inactivation of Src homology region 2-containing protein tyrosine phosphatase (SHP)-2. 30 Similar to our results with thrombin, a recent study has shown that deficiency of Nox1 in SMCs reduces [Ca 2ϩ ] i in response to Ang II. 9 These findings were attributed to abnormalities in trafficking of the Ang II type 1 receptor to the plasma membrane. In our study, activation of IP 3 was similar in WT and Nox1 null cells, indicating that, in contrast to the response to Ang II, the blunted increase in [Ca 2ϩ ] i in Nox1 null cells to thrombin is not attributed to dysregulation of thrombin receptor signaling or trafficking.
Nox1 has been shown to be integral for migration of SMCs. SMC migration involves a complicated and coordinated series of steps and is an important component of vascular remodeling. Transient changes in [Ca 2ϩ ] i are likely to be a key regulating signal for migration of SMCs. 40 Our data demonstrate that Nox1 is required for migration of SMCs. We extend these findings to implicate a role for Ca 2ϩ influx in Nox1-mediated migration. Similarly, the inhibition of PTPs increased SMC migration in Nox1-deficient cells. This observation of increased migration in the absence of an agonist is consistent with thrombin causing Nox1-mediated inactivation of PTPs.
Perspectives
Increasing evidence defines a role for NADPH oxidases in the pathogenesis of vascular disease. In this study, we demonstrate that Nox1-derived ROS in SMCs are critical for changes in [Ca 2ϩ ] i via a mechanism that involves influx of extracellular Ca 2ϩ . These data provide direct evidence that Nox1 contributes to Ca 2ϩ homeostasis in SMCs and identifies potential redox-sensitive mechanisms of SMC activation, which is important in regulation of vascular tone. Although treatment with antioxidants showed promise in experimental models of hypertension and restenosis, results from large clinical trials have been disappointing. Future strategies that focus on Nox1 as a potential target have the potential to reduce the morbidity and mortality associated with cardiovascular disease.
